The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a medicine nearing pivotal testing.

Climb Bio ( ($CLYM) ) has issued an update. On December 11, 2025, Climb Bio, Inc. entered into an exchange agreement with RA Capital Management ...

Fintel reports that on December 18, 2025, Chardan Capital maintained coverage of SAB Biotherapeutics (NasdaqCM:SABS) with a ...

Lions' Amon-Ra St. Brown makes football history never done before in the NFL originally appeared on The Sporting News. Add ...

Today (December 19), the working group of the Central Disaster Prevention Council of the Japanese government released a new ...

The capital outlay of 25 states grew 3.7 per cent yoy during 2QFY26, leading to an improvement in the quality of states’ ...

Also: How Philip Rivers won over the Colts, an overlooked Coach of the Year candidate and the NFL's grossest touchdown ...

During the early stages of the pandemic, SPAC mergers were the route that many medtech companies took to go public.

Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million series B the biotech will use to take its lead molecular glue degrader into the ...

Is Ra’am sincere or just engaged in political theater, attempting to survive a process that would render it an outlaw?The post Ra’am declares split from Islamic movement, analysts say it’s ...

I wonder whether the complexity of Blue Owl’s structure, the inherent opacity of publicly traded private credit and stress to ...

A deadline from the Kansas government looms for the Kansas City Chiefs and Royals to make a deal for subsidies to build new ...